// App-Quantinova.ai

: EFFECT OF IN VIVO HYDROXYCHLOROQUINE AND EX VIVO ANTI-BDCA2 TREATMENT ON PDC IFNα PRODUCTION FROM PATIENTS AFFECTED WITH CUTANEOUS LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • Agnes Gardet

Principal Investigators

  • Alex Pellerin

  • Christie-Ann Mccarl

  • Rohan Diwanji

  • Wenting Wang

  • Douglas Donaldson

  • Nathalie Franchimont

  • Victoria Werth

  • Dania Rabah

Medical Centers

  • Cardiio Inc., Cambridge, United States of America

  • Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

Disease

  • Cutaneous lupus erythematosus

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Hydroxychloroquine

  • BIIB-059

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved